These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 33558427)

  • 1. Stem Cell Therapies in Alzheimer's Disease: Applications for Disease Modeling.
    Si Z; Wang X
    J Pharmacol Exp Ther; 2021 May; 377(2):207-217. PubMed ID: 33558427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem-cell challenges in the treatment of Alzheimer's disease: a long way from bench to bedside.
    Fan X; Sun D; Tang X; Cai Y; Yin ZQ; Xu H
    Med Res Rev; 2014 Sep; 34(5):957-78. PubMed ID: 24500883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human iPSC application in Alzheimer's disease and Tau-related neurodegenerative diseases.
    Tcw J
    Neurosci Lett; 2019 Apr; 699():31-40. PubMed ID: 30685408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem Cell Therapy for Alzheimer's Disease.
    Han F; Bi J; Qiao L; Arancio O
    Adv Exp Med Biol; 2020; 1266():39-55. PubMed ID: 33105494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced pluripotent stem cells in Alzheimer's disease: applications for disease modeling and cell-replacement therapy.
    Yang J; Li S; He XB; Cheng C; Le W
    Mol Neurodegener; 2016 May; 11(1):39. PubMed ID: 27184028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced Pluripotent Stem Cell-Derived Neural Precursors Improve Memory, Synaptic and Pathological Abnormalities in a Mouse Model of Alzheimer's Disease.
    Armijo E; Edwards G; Flores A; Vera J; Shahnawaz M; Moda F; Gonzalez C; Sanhueza M; Soto C
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal Stem Cell-Derived Exosomes as a Neuroregeneration Treatment for Alzheimer's Disease.
    Shah S; Mansour HM; Aguilar TM; Lucke-Wold B
    Biomedicines; 2024 Sep; 12(9):. PubMed ID: 39335626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease.
    Pinheiro L; Faustino C
    Curr Alzheimer Res; 2019; 16(5):418-452. PubMed ID: 30907320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem Cell Therapies for Neurodegenerative Diseases.
    Sugaya K; Vaidya M
    Adv Exp Med Biol; 2018; 1056():61-84. PubMed ID: 29754175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult neurogenesis, neural stem cells and Alzheimer's disease: developments, limitations, problems and promises.
    Taupin P
    Curr Alzheimer Res; 2009 Dec; 6(6):461-70. PubMed ID: 19747153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss.
    Ager RR; Davis JL; Agazaryan A; Benavente F; Poon WW; LaFerla FM; Blurton-Jones M
    Hippocampus; 2015 Jul; 25(7):813-26. PubMed ID: 25530343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity.
    Forest KH; Nichols RA
    Trends Mol Med; 2019 Aug; 25(8):685-695. PubMed ID: 31248781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cell therapy for Alzheimer's disease.
    Abdel-Salam OM
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):459-85. PubMed ID: 21495961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Pluripotent Stem Cells as In Vitro Models of Neurodegenerative Diseases.
    Machairaki V
    Adv Exp Med Biol; 2020; 1195():93-94. PubMed ID: 32468463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3D culture models of Alzheimer's disease: a road map to a "cure-in-a-dish".
    Choi SH; Kim YH; Quinti L; Tanzi RE; Kim DY
    Mol Neurodegener; 2016 Dec; 11(1):75. PubMed ID: 27938410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why Is Research on Amyloid-β Failing to Give New Drugs for Alzheimer's Disease?
    Doig AJ; Del Castillo-Frias MP; Berthoumieu O; Tarus B; Nasica-Labouze J; Sterpone F; Nguyen PH; Hooper NM; Faller P; Derreumaux P
    ACS Chem Neurosci; 2017 Jul; 8(7):1435-1437. PubMed ID: 28586203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer's disease.
    Marei HE; Khan MUA; Hasan A
    Cell Mol Biol Lett; 2023 Nov; 28(1):98. PubMed ID: 38031028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cell-derived extracellular vesicles: a glimmer of hope in treating Alzheimer's disease.
    Liew LC; Katsuda T; Gailhouste L; Nakagama H; Ochiya T
    Int Immunol; 2017 Jan; 29(1):11-19. PubMed ID: 28184439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.